Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Exact Sciences Corporation Financials Banner

Exact Sciences Corporation Financials

EXAS Stock Analysis

Page title

Section title

EXAS Income Statement Key Metrics

  • Revenue(TTM)2.61 B
  • Gross Profit(TTM)1.89 B
  • EBITDA(TTM)-2.37 M
  • Net Income(TTM)-175.01 M
  • EPS Diluted(TTM)-0.9515

Decode EXAS's Latest Earnings Call with Ease

Tap 'Generate' for a crystal-clear,
AI-crafted summary and stay ahead in the investment game!

EXAS earnings and revenue history

EXAS Return on Equity

See how efficiently EXAS generates profit for it's shareholders.

-6.49%

10
0
100
  1. Poor

  2. Average

  3. Strong

Return on Equity Growth

EXAS's Return on Equity has shown poor growth over the past 10 years, increasing by only -15.41%.

EXAS Revenue Growth

See how EXAS has grown it's revenue over the past 10 years.


Revenue Growth

EXAS's revenue has grown significantly over the past 10 years, increasing by over 106.21%.

EXAS FY, 2023 Revenue Breakdown

See how EXAS converts it's revenue into profit.

EXAS Balance Sheet Health

EXAS Balance Sheet Breakdown 2023

Assets

  1. Long Term Assets

  2. Cash & Equivalents

  3. Inventory

  4. Receivables

  5. Property Plant Equipments

  6. Others

Liabilities

  1. Short Term Debt

  2. Long Term Debt

  3. Account Payables

  4. Others

EXAS financial position analysis

Short Term Liabilities

EXAS's short term assets($1B) can safely cover it's short term liabilities($515M).

Long Term Liabilities

EXAS's short term assets($1B) cannot safely cover it's long term liabilities($3B).

EXAS Debt to Equity